Star Equity (STRR) Competitors $2.17 -0.09 (-3.98%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends STRR vs. COCH, BDMD, RVP, SURG, DRIO, IRIX, DHAI, VVOS, NXGL, and XAIRShould you be buying Star Equity stock or one of its competitors? The main competitors of Star Equity include Envoy Medical (COCH), Baird Medical Investment (BDMD), Retractable Technologies (RVP), SurgePays (SURG), DarioHealth (DRIO), IRIDEX (IRIX), DIH Holding US (DHAI), Vivos Therapeutics (VVOS), NEXGEL (NXGL), and Beyond Air (XAIR). These companies are all part of the "medical equipment" industry. Star Equity vs. Envoy Medical Baird Medical Investment Retractable Technologies SurgePays DarioHealth IRIDEX DIH Holding US Vivos Therapeutics NEXGEL Beyond Air Star Equity (NASDAQ:STRR) and Envoy Medical (NASDAQ:COCH) are both small-cap multi-sector conglomerates companies, but which is the better business? We will compare the two companies based on the strength of their risk, community ranking, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation. Which has more volatility & risk, STRR or COCH? Star Equity has a beta of 0.07, indicating that its stock price is 93% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.4, indicating that its stock price is 140% more volatile than the S&P 500. Does the MarketBeat Community favor STRR or COCH? Envoy Medical received 4 more outperform votes than Star Equity when rated by MarketBeat users. CompanyUnderperformOutperformStar EquityOutperform Votes3100.00% Underperform VotesNo VotesEnvoy MedicalOutperform Votes7100.00% Underperform VotesNo Votes Do institutionals and insiders hold more shares of STRR or COCH? 3.8% of Star Equity shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 33.5% of Star Equity shares are held by insiders. Comparatively, 60.5% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is STRR or COCH more profitable? Star Equity has a net margin of -12.41% compared to Envoy Medical's net margin of -7,607.55%. Envoy Medical's return on equity of 0.00% beat Star Equity's return on equity.Company Net Margins Return on Equity Return on Assets Star Equity-12.41% -8.72% -4.62% Envoy Medical -7,607.55%N/A -262.28% Do analysts rate STRR or COCH? Envoy Medical has a consensus price target of $8.00, suggesting a potential upside of 457.49%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than Star Equity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Star Equity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer STRR or COCH? In the previous week, Star Equity had 3 more articles in the media than Envoy Medical. MarketBeat recorded 4 mentions for Star Equity and 1 mentions for Envoy Medical. Star Equity's average media sentiment score of 0.94 beat Envoy Medical's score of 0.62 indicating that Star Equity is being referred to more favorably in the media. Company Overall Sentiment Star Equity Positive Envoy Medical Positive Which has better earnings & valuation, STRR or COCH? Star Equity has higher revenue and earnings than Envoy Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStar Equity$50.38M0.14$25.13M-$2.57-0.88Envoy Medical$278K104.50-$29.91MN/AN/A SummaryEnvoy Medical beats Star Equity on 9 of the 15 factors compared between the two stocks. Remove Ads Get Star Equity News Delivered to You Automatically Sign up to receive the latest news and ratings for STRR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STRR vs. The Competition Export to ExcelMetricStar EquityElectromedical equipment IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$7.24M$3.39B$12.51B$7.95BDividend YieldN/A1.60%3.37%4.05%P/E Ratio-0.8815.2810.0618.79Price / Sales0.1444.544.13119.12Price / Cash6.1144.0911.3334.64Price / Book0.153.262.064.21Net Income$25.13M$94.03M$885.89M$247.07M7 Day Performance2.27%-4.88%-1.34%-2.44%1 Month Performance5.63%-12.07%-5.25%-10.43%1 Year Performance-50.55%-12.55%-9.40%0.94% Star Equity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STRRStar Equity1.3509 of 5 stars$2.15-4.9%N/A-48.6%$6.92M$50.38M-0.84460News CoverageCOCHEnvoy Medical1.9748 of 5 stars$1.33-2.9%$8.00+501.5%-80.7%$26.93M$278,000.000.0034News CoveragePositive NewsBDMDBaird Medical InvestmentN/A$3.67-10.0%N/AN/A$24.16M$33.05M0.00N/ARVPRetractable TechnologiesN/A$0.80+3.8%N/A-38.8%$23.92M$38.27M-1.48240Analyst ForecastNews CoverageGap DownSURGSurgePays3.0051 of 5 stars$1.15-10.2%$8.50+639.1%-81.5%$23.19M$83.60M-1.0240DRIODarioHealth2.5452 of 5 stars$0.64-7.8%$2.50+289.5%-60.6%$21.88M$23.05M-0.68200Analyst ForecastNews CoverageIRIXIRIDEX1.7375 of 5 stars$1.26-8.7%$2.00+58.7%-52.3%$20.96M$48.43M-1.88120News CoverageGap DownDHAIDIH Holding US0.4982 of 5 stars$0.43-11.9%N/A-70.6%$20.29M$64.47M-1.43N/AShort Interest ↑Gap DownVVOSVivos Therapeutics1.7376 of 5 stars$3.30-4.9%$6.30+90.9%-30.4%$19.44M$14.58M-0.58160Short Interest ↑NXGLNEXGEL1.2996 of 5 stars$2.85-8.1%N/A+5.6%$19.35M$6.73M-4.9110News CoveragePositive NewsXAIRBeyond Air4.3431 of 5 stars$0.26-4.0%$3.67+1,315.7%-84.4%$17.82M$3.02M-0.2470Short Interest ↑Positive NewsGap Up Remove Ads Related Companies and Tools Related Companies Envoy Medical Competitors Baird Medical Investment Competitors Retractable Technologies Competitors SurgePays Competitors DarioHealth Competitors IRIDEX Competitors DIH Holding US Competitors Vivos Therapeutics Competitors NEXGEL Competitors Beyond Air Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STRR) was last updated on 3/13/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Star Equity Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Star Equity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
